Jerusalem Global Ventures
VC Fund
Jerusalem, Israel
Jerusalem Global Ventures is a VC fund in Jerusalem focused on Software and Information Technology. Jerusalem Global's goal has been to support private Israeli technology initiatives and to generate superior returns to investors. Over the last two decades, the partners of Jerusalem Global Ventures have developed strong ties with the top Israeli entrepreneurs and visionaries enabling JGV to invest in the best of Israel's entrepreneurs and help their portfolio companies build winning management teams.
- Total investments:
- 32
- Last investment:
- Lead investor:
- 28%
- Fund size:
- $200M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Jerusalem Global Ventures invests in
Stages Jerusalem Global Ventures invests in
Countries Jerusalem Global Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $2M–$20M
- Series B
- $6M–$14M
- Series C
- $5.8M–$56M
Investment Focus
Industry
- Software 6 (19%)
- Information Technology 5 (16%)
- Mobile 4 (13%)
- Biotechnology 4 (13%)
- Internet 3 (9%)
Stage
- Series A 11 (34%)
- Series B 5 (16%)
- Series C 5 (16%)
- Funding Round 4 (13%)
- Series D 2 (6%)
Country
- United States 12 (38%)
- Israel 11 (34%)
- Canada 1 (3%)
- United Kingdom 1 (3%)
- The Netherlands 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Shlomo Kalish
Founder and General Partner
|
Founder and General Partner | Total investments: 7 | Find email | |
Daniel Reich
Partner & Chief Operating Officer
|
Partner & Chief Operating Officer | Total investments: 0 | Find email | |
Ranan Grobman
General Partner
|
General Partner | Total investments: 7 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Quiet Therapeutics is an emerging biotech company founded in 2010 developing a proprietary nanoparticle-based delivery system (gagomers) focused on oncology and inflammation.Based on the targeting capability of our innovative technology, the company is well positioned to expand the drug target repertoire in cancer and inflammation. The Gagomerdelivery approach enables us to target cell components that are not manageable by other therapeutic agents like small molecules or antibodies. | $12M / Series A / Apr 12, 2015 | ||
| Moovit is a Mobility as a Service (MaaS) provider and the world’s #1 transit app. Moovit simplifies your urban mobility in +2700 cities all around the world, making getting around town via mass transit easier and more convenient. Moovit has more than 300 million users, and was named Best Local App of 2016 by Google and Best of 2017 app by Apple.By combining information from public transit operators and authorities with live information from the user community, Moovit offers travelers a real-time picture, including the best route for their journey. The Moovit community sends active reports about their travel experience, such as bus congestion levels, cleanliness, and more to help others have a better travel experience.Moovit generates up to four billion anonymous data points a day that comprise the world's largest repository of transit data. The Big Data gathering is aided by Moovit’s network of more than 500,000 local editors, called “Mooviters”, who help map out and maintain local transit information in cities that would otherwise be unserved.Moovit is available for free on iOS, Android & Web in over 2,700 cities, across 86 countries worldwide, and can be used in 44 languages. | $50M / Series C / Jan 14, 2015 | ||
| SolarEdge Technologies, a global leader in the DC power optimizer market. The company provides module-level electronics for solar power harvesting and monitoring systems for residential, commercial and utility-scale solar photovoltaic installers. The SolarEdge portfolio of products includes power optimizers and a web portal for module-leveloptimization and monitoring, as well as PV inverters, specialized to work with power optimizers. SolarEdge envisions that every solar module will be individually managed by DC-DC module-level electronics, accelerating the pace towards grid parity and making clean energy affordable.Founded in 2006, SolarEdge established the DC power optimizer segment and is leading it with over 70% market share. By Q4 2012, SolarEdge has shipped over 1,600,000 power optimizers to more than 40 countries worldwide. With strategic partnerships across the PV value-chain from module manufacturers to integrators, SolarEdge installations can be found in five continents. | Series E / Sep 01, 2014 | ||
| Altair is a fabless semiconductor company based in Israel that is developing state of the art, ultra low power mobile WiMAX silicon solutions optimized for handsets and handheld devices.Altair was founded in May 2005 by former Texas Instruments executives with extensive broadband and wireless silicon experience. Their products are thesmallest, lowest power solutions in the industry, offering superb mobility performance and enabling the migration of WiMAX from a fixed wireless PC technology to a true next generation mobile technology.Altair's management and technology executives were among the founding team of Libit Signal Processing, a fabless chip company acquired by Texas Instruments in 1999 for $365 million. The company's world class scientists, algorithm, VLSI and software engineers have in the past, jointly developed over twenty complex mixed-signal silicon products, spanning six different broadband wired and wireless technologies.Altair is a principal member of the WiMAX Forum and a member of the IEEE802.16e. | $25M / Series F / Jun 06, 2014 | ||
| Wilocity Ltd. develops 60 GHz wireless chipsets for the notebook and peripheral markets. Its wireless solution provides gigabit wireless networking and point-to-point connectivity. The company's gigabit wireless semiconductor solution brings a desktop experience to mobile computers. Wilocity Ltd. was founded in 2007 and is based in Caesarea,Israel. | $35M / Series D / Oct 15, 2013 | ||
| MacroCure is a biotechnology company focused on the development and commercialization of advanced cell therapy products. The company's first focus of interest is in the arena of wound care. The technology employs activated white blood cells obtained from young adults healthy donor blood. The activated cells provide the natural environment forwound healing, and ensure that necessary cell activities and factor secretions are maintained as required for wound healing. This novel concept is the first of its kind in the field of wound therapy. | $35M / Series A / May 14, 2012 | ||
| Storone provides information storage system facilities for small and medium enterprises businesses. It currently develops a software platform to distribute large scale storage system. Storone is an Israel-based company that was founded in 2012 by Gal Naor. | $20M / Series A / Mar 21, 2012 | ||
| Ginger specializes in developing mobile keyboard and writing enhancement apps that enable everyone to quickly write high-quality, accurate messages. Ginger has developed the NLP platform (natural language processing), which is the foundation for its advanced text analysis applications. This platform lies at the core of all of Ginger's mobile,web-based and PC products. | $6.3M / Series D / Feb 28, 2012 | ||
| Powermat’s solutions provide a hybrid approach to wireless power, bridging the gap between magnetic induction and resonance, providing more power, freedom, and connectivity. Powermat's innovative platforms provide both standard-based (Qi®) and proprietary wireless power technology for automotive, robotics, drones, consumer electronics, medicaldevices, IoT, telecom (5G), and Industrial applications. The company's software-based end-to-end wireless power platforms, which can be integrated into any standard microcontroller, provide a unique approach that offers more flexibility in design (e.g., coil form factor) and enables our customers to tailor-fit smart power solutions with data connectivity at a lower cost. To-date, Powermat has over 200 patent submissions, 100+ granted patents dating back to 2007 (pre-standards). | $80M / Oct 06, 2011 | ||
| Prime Sense's concept is a device, which allows a computer to perceive the world in 3D and derive an understanding of the world based on sight, just the way humans do.On March 31, 2010, PrimeSense confirmed that it was the technology behind Microsoft's much-touted "Project Natal".The device includes a sensor, which seesa user (including their complete surroundings), and a digital component, or "brain" which learns and understands user movement within those surroundings. Prime Sense's interactive device can see, track and react to user movements outside the computer, all without change of environment or wearable equipment for the end user. The closed device is plug and play and platform independent.The company envisages the following uses: -Interact with video games by using body movement and gestures. -Interact with digital devices using menus on a screen as opposed to mouse and keyboard-Improved video communication with for example virtual backgrounds and virtual drawing boards. | $10M / Series C / Jun 20, 2011 | ||
| See all 32 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Jerusalem Global Ventures invest in?
Jerusalem Global Ventures invests primarily in Software, Information Technology and Mobile startups, most often at Series A and Series B stage. Most of the 32 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Jerusalem Global Ventures invest in?
Jerusalem Global Ventures typically joins rounds of $2M–$20M at Series A, $6M–$14M at Series B and $5.8M–$56M at Series C. These are whole funding-round sizes, not Jerusalem Global Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Jerusalem Global Ventures took part in.
How do I contact Jerusalem Global Ventures?
Public channels for Jerusalem Global Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Jerusalem Global Ventures?
The team at Jerusalem Global Ventures includes Shlomo Kalish (Founder and General Partner), Daniel Reich (Partner & Chief Operating Officer) and Ranan Grobman (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
